Saturday, August 1, 2026

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

ARMISTICE SHATTERED: North Korea Violates Treaty—South Korea’s Military Response Confirms Crisis

North Korean troops breached the MDL in the DMZ, prompting South Korea to propose military talks after days of silence from Pyongyang.

Trump’s 25% Tariff Clock Keeps Ticking: Seoul Races a U.S. Investment Law — But Washington’s Complaints Now Go Beyond Investment

U.S. tariffs on South Korea may rise due to investment delays, impacting trade and security talks, despite legislative efforts.

Tag: global

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

What Makes DOOTH the Game-Changer in Absorbable Sutures? Discover Its Unique Advantages!

CGBio is expanding its aesthetic business by exporting the absorbable suture DOOTH to Japan, aiming for global recognition and regulatory approvals.

AI Cold War: China Expands Influence Across Developing World

China is advancing in AI, challenging US dominance and appealing to developing countries with affordable technology, says economist Rory Green.

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

JW Pharmaceutical Advances Gout Treatment with Epaminurad

JW Pharmaceutical advances its gout treatment, Epaminurad, with global trials nearing completion and U.S. patent secured for market entry.

VUNO Secures 10 Billion KRW Investment: What’s Next for AI in Healthcare?

Vuno secures 10 billion KRW investment for global expansion of its AI cardiac arrest device, DeepCARS, enhancing its market position.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

K-Beauty Boom: How Classys, Hugel, and Wontech are Expanding in Global Markets

The K-beauty industry is growing, leveraging strong manufacturing and R&D capabilities alongside the global spread of Hallyu.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

How Seers’ mobiCARE and thynC are Transforming Heart Disease Management in Asia

Seers Technology is revolutionizing digital healthcare with AI and wearable tech, achieving strong growth and targeting international markets.

Unlocking Global Potential: ezCaretech’s AI-Driven Healthcare Solutions for Saudi Arabia

ezCaretech is expanding into the Middle East, focusing on Saudi Arabia, with innovative healthcare technology and global partnerships.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.